Safety of intra-arterial chemotherapy with or without osmotic blood–brain barrier disruption for the treatment of patients with brain tumorsKutluay Uluç, Edward A. Neuwelt, Cymon Kersch et al.|Neuro-Oncology Advances|2022Cited by 24
NTOX-09. RECOMMENDED PHASE II DOSE OF INTRA-ARTERIAL MELPHALAN GIVEN WITH INTRA-ARTERIAL CARBOPLATIN, OSMOTIC BLOOD-BRAIN BARRIER DISRUPTION AND DELAYED OTOPROTECTIVE SODIUM THIOSULFATE FOR PATIENTS WITH RECURRENT OR PROGRESSIVE CNS EMBRYONAL OR GERM CELL TUMORSPrakash Ambady, Edward A. Neuwelt, Nancy D. Doolittle et al.|Neuro-Oncology|2017Cited by 0